DAILY UPDATE
September 25, 2017
Greetings!

I continue to get lots of questions about the ads for Paul Mampilly's "#1 stock for 2018", so we're sharing that solution with you today, dear readers -- the Irregulars saw this piece about five weeks ago, but now I've posted the teaser solution for everyone.  What's this "Greatest Medical Breakthrough in History" stock?  Just click below to...

Legalization of marijuana for medicinal and recreational use is creating a multibillion-dollar industry. But don't think you have to chase risky penny stocks to profit. This list of 5 proven names have the scale and regulatory know-how to dominate this emerging industry in the coming years. Get the names of these 5 marijuana stocks now!
Advertisement
Miss anything last week?

We started with a look at the stock Tom Gardner thinks will go up 5X for Motley Fool subscribers (and that he's buying with the Motley Fool's money)... what's that?  Answers here.

We then turned our gaze to Cabot's Stock of the Week service, which is promising to double your money in the next 12 months -- and they say they can do that because they're picking huge winners, like this Chinese hotel company that they think will post 1,120% returns in the next four years.  That "secret" is discussed here.

And Cyber-security was the pitch from Hilary Kramer this week, she's got the stock she thinks will stop North Korea's hackers... click here for our look at that one.

Then it was back to gold again, with a pitch from Moe Zulfiqar... his ad says that "This Tiny Stock Is Such a Bargain the Company Spent $20 Million to Buy Its Own Stock!"  That sounds exciting, right?   Well, there's a little bit of hair stuck to that assertion at the moment... we look into the story here.

Finally, we closed things out with the Friday File -- a look at a few gold and royalty companies that have had some news in my Real Money Portfolio, plus a quick check on a teaser about a "big data" company with incredible growth, Irregulars can see that one here.

IRREGULARS CORNER

Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060
Sent by travis@stockgumshoe.com in collaboration with
Constant Contact